{"pmid":32228322,"title":"COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus.","text":["COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus.","The pandemic of COVID-19, a disease caused by a novel coronavirus (CoV), SARS-CoV-2, is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on severe acute respiratory syndrome, SARS-CoV, and Middle East respiratory syndrome, MERS-CoV, and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.","Am J Physiol Endocrinol Metab","Muniyappa, Ranganath","Gubbi, Sriram","32228322"],"abstract":["The pandemic of COVID-19, a disease caused by a novel coronavirus (CoV), SARS-CoV-2, is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on severe acute respiratory syndrome, SARS-CoV, and Middle East respiratory syndrome, MERS-CoV, and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes."],"journal":"Am J Physiol Endocrinol Metab","authors":["Muniyappa, Ranganath","Gubbi, Sriram"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228322","week":"202014|Mar 30 - Apr 05","doi":"10.1152/ajpendo.00124.2020","keywords":["COVID-19","Coronavirus","Diabetes Mellitus"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1662899337677504512,"score":7.3910046,"similar":[{"pmid":32226286,"pmcid":"PMC7098031","title":"Zoonotic origins of human coronaviruses.","text":["Zoonotic origins of human coronaviruses.","Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted.","Int J Biol Sci","Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan","32226286"],"abstract":["Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted."],"journal":"Int J Biol Sci","authors":["Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226286","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45472","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","animal reservoir","bats","coronavirus"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1662819280313384960,"score":186.52695},{"pmid":32233018,"title":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.","text":["Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.","A novel RNA betacoronavirus causing coronavirus disease 2019 (Covid-19) has now been declared pandemic disease by WHO. Guo W et al published the first report of biochemical features in patients with diabetes and the further risk that this disease can determine to the progression of Covid-19. Among different cytokines found significantly higher in patients with diabetes compared to those without, Interleukin-6 (IL-6) which is already increased in conditions of chronic inflammation, may play a more deleterious role in Covid-19 infection. Targeting the over expression of Il-6 effects with a monoclonal antibody against IL-6 receptor or using Janus Kinase inhibitors may be particularly helpful for treatment of Covid-19 pneumonia in diabetes. This article is protected by copyright. All rights reserved.","Diabetes Metab Res Rev","Maddaloni, Ernesto","Buzzetti, Raffaella","32233018"],"abstract":["A novel RNA betacoronavirus causing coronavirus disease 2019 (Covid-19) has now been declared pandemic disease by WHO. Guo W et al published the first report of biochemical features in patients with diabetes and the further risk that this disease can determine to the progression of Covid-19. Among different cytokines found significantly higher in patients with diabetes compared to those without, Interleukin-6 (IL-6) which is already increased in conditions of chronic inflammation, may play a more deleterious role in Covid-19 infection. Targeting the over expression of Il-6 effects with a monoclonal antibody against IL-6 receptor or using Janus Kinase inhibitors may be particularly helpful for treatment of Covid-19 pneumonia in diabetes. This article is protected by copyright. All rights reserved."],"journal":"Diabetes Metab Res Rev","authors":["Maddaloni, Ernesto","Buzzetti, Raffaella"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233018","week":"202014|Mar 30 - Apr 05","doi":"10.1002/dmrr.3321","keywords":["Covid-19","Diabetes","Inflammation; IL-6"],"source":"PubMed","locations":["Janus"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1662899337716301824,"score":184.08075},{"pmid":32100877,"title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.","text":["Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.","From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively. Currently, a novel coronavirus (SARS-CoV-2), which has become the cause of the outbreak of Coronavirus Disease 2019 (COVID-19), was discovered. Until 18 February 2020, there were 72 533 confirmed COVID-19 cases (including 10 644 severe cases) and 1872 deaths in China. SARS-CoV-2 is spreading among the public and causing substantial burden due to its human-to-human transmission. However, the intermediate host of SARS-CoV-2 is still unclear. Finding the possible intermediate host of SARS-CoV-2 is imperative to prevent further spread of the epidemic. In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans.","J Med Virol","Liu, Zhixin","Xiao, Xiao","Wei, Xiuli","Li, Jian","Yang, Jing","Tan, Huabing","Zhu, Jianyong","Zhang, Qiwei","Wu, Jianguo","Liu, Long","32100877"],"abstract":["From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively. Currently, a novel coronavirus (SARS-CoV-2), which has become the cause of the outbreak of Coronavirus Disease 2019 (COVID-19), was discovered. Until 18 February 2020, there were 72 533 confirmed COVID-19 cases (including 10 644 severe cases) and 1872 deaths in China. SARS-CoV-2 is spreading among the public and causing substantial burden due to its human-to-human transmission. However, the intermediate host of SARS-CoV-2 is still unclear. Finding the possible intermediate host of SARS-CoV-2 is imperative to prevent further spread of the epidemic. In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans."],"journal":"J Med Virol","authors":["Liu, Zhixin","Xiao, Xiao","Wei, Xiuli","Li, Jian","Yang, Jing","Tan, Huabing","Zhu, Jianyong","Zhang, Qiwei","Wu, Jianguo","Liu, Long"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32100877","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25726","keywords":["Coronavirus Disease 2019 (COVID-19)","SARS-CoV-2","SARS-CoV-2 spike protein (S)","angiotensin-converting enzyme 2 (ACE2)","receptor-binding domain (RBD) of coronavirus"],"source":"PubMed","locations":["China","Chelonia","Pelodiscus"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Mechanism"],"weight":1,"_version_":1662334544270852096,"score":175.53523},{"pmid":32219363,"title":"Potential Effects of Coronaviruses on the Cardiovascular System: A Review.","text":["Potential Effects of Coronaviruses on the Cardiovascular System: A Review.","Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system. Observations: Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications. A large proportion of patients have underlying cardiovascular disease and/or cardiac risk factors. Factors associated with mortality include male sex, advanced age, and presence of comorbidities including hypertension, diabetes mellitus, cardiovascular diseases, and cerebrovascular diseases. Acute cardiac injury determined by elevated high-sensitivity troponin levels is commonly observed in severe cases and is strongly associated with mortality. Acute respiratory distress syndrome is also strongly associated with mortality. Conclusions and Relevance: Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias. Extensive efforts are underway to find specific vaccines and antivirals against SARS-CoV-2. Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines.","JAMA Cardiol","Madjid, Mohammad","Safavi-Naeini, Payam","Solomon, Scott D","Vardeny, Orly","32219363"],"abstract":["Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system. Observations: Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications. A large proportion of patients have underlying cardiovascular disease and/or cardiac risk factors. Factors associated with mortality include male sex, advanced age, and presence of comorbidities including hypertension, diabetes mellitus, cardiovascular diseases, and cerebrovascular diseases. Acute cardiac injury determined by elevated high-sensitivity troponin levels is commonly observed in severe cases and is strongly associated with mortality. Acute respiratory distress syndrome is also strongly associated with mortality. Conclusions and Relevance: Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias. Extensive efforts are underway to find specific vaccines and antivirals against SARS-CoV-2. Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines."],"journal":"JAMA Cardiol","authors":["Madjid, Mohammad","Safavi-Naeini, Payam","Solomon, Scott D","Vardeny, Orly"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219363","week":"202013|Mar 23 - Mar 29","doi":"10.1001/jamacardio.2020.1286","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1662540582088605696,"score":167.36125},{"pmid":32105090,"title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.","text":["Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.","As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.","Asian Pac J Allergy Immunol","Prompetchara, Eakachai","Ketloy, Chutitorn","Palaga, Tanapat","32105090"],"abstract":["As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future."],"journal":"Asian Pac J Allergy Immunol","authors":["Prompetchara, Eakachai","Ketloy, Chutitorn","Palaga, Tanapat"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32105090","week":"20209|Feb 24 - Mar 01","doi":"10.12932/AP-200220-0772","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1662334544241491968,"score":165.96281}]}